Search research articles
Contact Us
Filters
Showing results (61-70 of 66) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 66 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2012
Randomized, open-label, phase III study comparing patupilone (EPO906) with pegylated liposomal doxorubicin in platinum-refractory or -resistant patients with recurrent epithelial ovarian, primary fallopian tube, or primary peritoneal cancer
Nicoletta Colombo, Elzbieta Kutarska, Meletios Dimopoulos, et al.
Heart Rhythm
|
December 14, 2011
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents
Dan Hu, Hector Barajas-Martínez, Argelia Medeiros-Domingo, et al.
JAMA
|
August 10, 2002
Sertraline treatment of major depression in patients with acute MI or unstable angina
Alexander H Glassman, Christopher M O'Connor, Robert M Califf, et al.
Cancer Research
|
July 22, 2010
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk
Elena Ratner, Lingeng Lu, Marta Boeke, et al.
Cardiovascular Research
|
February 19, 2015
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study
Elijah R Behr, Eleonora Savio-Galimberti, Julien Barc, et al.
JACC. Clinical Electrophysiology
|
February 19, 2021
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK)
Shohreh Honarbakhsh, Rui Providencia, Jorge Garcia-Hernandez, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 66) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 66 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2012
Randomized, open-label, phase III study comparing patupilone (EPO906) with pegylated liposomal doxorubicin in platinum-refractory or -resistant patients with recurrent epithelial ovarian, primary fallopian tube, or primary peritoneal cancer
Nicoletta Colombo, Elzbieta Kutarska, Meletios Dimopoulos, et al.
Heart Rhythm
|
December 14, 2011
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Na(v)1.5 and K(v)4.3 channel currents
Dan Hu, Hector Barajas-Martínez, Argelia Medeiros-Domingo, et al.
JAMA
|
August 10, 2002
Sertraline treatment of major depression in patients with acute MI or unstable angina
Alexander H Glassman, Christopher M O'Connor, Robert M Califf, et al.
Cancer Research
|
July 22, 2010
A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk
Elena Ratner, Lingeng Lu, Marta Boeke, et al.
Cardiovascular Research
|
February 19, 2015
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study
Elijah R Behr, Eleonora Savio-Galimberti, Julien Barc, et al.
JACC. Clinical Electrophysiology
|
February 19, 2021
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK)
Shohreh Honarbakhsh, Rui Providencia, Jorge Garcia-Hernandez, et al.
Page
of 7